{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:40:55Z","timestamp":1792644055957,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0138","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"337-347","source":"Crossref","is-referenced-by-count":90,"title":["Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology"],"prefix":"10.1053","volume":"14","author":[{"given":"Claudine","family":"Mazurier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysiane","family":"Hilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Fressinaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0138_RF1","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor defect in a patient with factor VIII deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF4","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1055\/s-0038-1650628","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"76","author":"Schneppenheim","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2141.1990.tb06371.x","article-title":"Evidence for a von Willebrand factor defect in factor VIII binding in three members of a family previously misdiagnosed mild haemophilia A and haemophilia A carriers: consequences for therapy and genetic counselling","volume":"76","author":"Mazurier","year":"1990","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0138_RF6","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization","volume":"92","author":"Jorieux","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2516.1997.tb00173.x","volume":"3","year":"1997","journal-title":"Haemophilia"},{"key":"10.1053\/beha.2001.0138_RF8","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood.V90.7.2515","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years","volume":"90","author":"Mannucci","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/ajh.2830400105","article-title":"Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII","volume":"40","author":"Lopez-Fernandez","year":"1992","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0138_RF10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-2141.1994.tb05127.x","article-title":"Biological effect of desmopressin in eight patients with type 2N (\u2018Normandy\u2019) von Willebrand disease","volume":"88","author":"Mazurier","year":"1994","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0138_RF11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0925-5710(96)00470-7","article-title":"Changes in factor VIII binding capacity of von Willebrand factor and factor VIII coagulant activity in two patients with type 2N von Willebrand disease after hemostatic treatment and during pregnancy","volume":"64","author":"Nishino","year":"1996","journal-title":"International Journal of Hematology"},{"key":"10.1053\/beha.2001.0138_RF12","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function","volume":"92","author":"Lenting","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-0037-1614927","article-title":"Factor VIII and von Willebrand factor","volume":"79","author":"Vlot","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-0037-1615834","article-title":"Regulation of factor VIII expression and activity by von Willebrand factor","volume":"82","author":"Kaufman","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0049-3848(87)90417-8","article-title":"Evidence that NH2-terminal but not COOH-terminal moiety of plasma von Willebrand factor binds to factor VIII","volume":"48","author":"Jorieux","year":"1987","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0138_RF16","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"Foster","year":"1987","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0138_RF17","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1182\/blood.V70.5.1679.1679","article-title":"Localization of a factor VIII binding domain on a 34 kilodalton fragment of the N-terminal portion of von Willebrand factor","volume":"70","author":"Takahashi","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF18","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1172\/JCI113721","article-title":"Inactivation of human factor VIII by activated protein C","volume":"82","author":"Koedam","year":"1988","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0138_RF19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1432-1033.1990.tb15481.x","article-title":"The effect of von Willebrand factor on activation of factor VIII by factor Xa","volume":"189","author":"Koedam","year":"1990","journal-title":"European Journal of Biochemistry"},{"key":"10.1053\/beha.2001.0138_RF20","doi-asserted-by":"crossref","first-page":"23734","DOI":"10.1074\/jbc.274.34.23734","article-title":"The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein","volume":"274","author":"Lenting","year":"1999","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0138_RF21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V60.1.201.201","article-title":"A variant of von Willebrand's disease with abnormal expression of factor VIII procoagulant activity","volume":"60","author":"Montgomery","year":"1982","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V87.3.1013.bloodjournal8731013","article-title":"The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor","volume":"87","author":"Kroner","year":"1996","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650567","article-title":"Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease\u2014results of an international survey\u2014on behalf of the subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the ISTH","volume":"76","author":"Mazurier","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1046\/j.1365-2141.1998.00940.x","article-title":"Type 2N von Willebrand disease due to Arg91Gln substitution and a cytosine deletion in exon 18 of the von Willebrand factor gene","volume":"103","author":"Casonato","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0138_RF25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<311::AID-AJH11>3.0.CO;2-A","article-title":"Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor","volume":"58","author":"Miller","year":"1998","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0138_RF26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1055\/s-0038-1649651","article-title":"Functional analysis of the Arg91Gln substitution in the factor-VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression","volume":"70","author":"Lavergne","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1055\/s-0038-1650401","article-title":"Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques","volume":"75","author":"Nesbitt","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF28","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The Normandy variant of von Willebrand disease\u2014characterization of a point mutation in the von Willebrand factor gene","volume":"77","author":"Gaucher","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF29","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.1073\/pnas.88.14.6377","article-title":"Expression of von Willebrand factor Normandy\u2014an autosomal mutation that mimics hemophilia-A","volume":"88","author":"Tuley","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0138_RF30","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood.V89.9.3263","article-title":"Patient with type 2N von Willebrand disease is heterozygous for a new mutation: Gly22Glu. Demonstration of a defective expression of the second allele by the use of monoclonal antibodies","volume":"89","author":"Gu","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF31","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"95","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF32","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V95.10.3139","article-title":"Conformational changes in the D\u2032 domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment","volume":"95","author":"Jorieux","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1055\/s-0038-1657568","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene","volume":"78","author":"Meyer","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00217358","article-title":"Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation","volume":"91","author":"Wise","year":"1993","journal-title":"Human Genetics"},{"key":"10.1053\/beha.2001.0138_RF35","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1055\/s-0037-1614329","article-title":"A common splice site mutation is shared by two families with different type 2N von Willebrand disease mutations","volume":"82","author":"Nesbitt","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF36","first-page":"281","article-title":"Identification of two closely located new type 2N VWD mutations (Tyr32Cys and Met37Val)","volume":"82","author":"Hilbert","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1365-2141.1991.tb04480.x","article-title":"Identification of two point mutations in the von Willebrand factor gene of three families with the Normandy variant of von Willebrand disease","volume":"78","author":"Gaucher","year":"1991","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0138_RF38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood.V79.3.563.563","article-title":"The mutation Arg(53)\u2192Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII\u2014studies with recombinant von Willebrand factor","volume":"79","author":"Jorieux","year":"1992","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0138_RF39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/ajh.2830480228","article-title":"A case of recessive type 2N von Willebrand's disease due to Arg 53 Trp substitution","volume":"48","author":"Perez-Casal","year":"1995","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0138_RF40","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1016\/S0021-9258(18)92725-0","article-title":"Molecular characterization of a unique von Willebrand disease variant\u2014a novel mutation affecting von Willebrand factor\/factor VIII interaction","volume":"266","author":"Cacheris","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0138_RF41","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1016\/S0021-9258(18)54972-3","article-title":"Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease","volume":"266","author":"Kroner","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0138_RF42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.1992.tb08145.x","volume":"80","author":"Peerlinck","year":"1992","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0138_RF43","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0140-6736(93)91070-3","article-title":"Recessive inheritance of von Willebrand's disease type I","volume":"341","author":"Eikenboom","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/beha.2001.0138_RF44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00210590","article-title":"A novel case of compound heterozygosity with Normandy\/type I von Willebrand disease (vWD)\u2014direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD","volume":"93","author":"Siguret","year":"1994","journal-title":"Human Genetics"},{"key":"10.1053\/beha.2001.0138_RF45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0037-1615134","article-title":"Type 2N von Willebrand disease: rapid genetic diagnosis of G2811A (R854Q), C2696T (R816W), T2701A (H817Q) and G2823T (C858F)\u2014detection of a novel candidate type 2N mutation: C2810T (R854W)","volume":"80","author":"Bowen","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF46","first-page":"282","article-title":"Identification of a new type 2N vWD mutation (Gln290His) in the D3 domain of von Willebrand factor","volume":"82","author":"Hilbert","year":"1999","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0138_RF47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0038-1653772","article-title":"Very low frequency of \u2018Normandy type\u2019 mutations among type 1 von Willebrand disease families","volume":"73","author":"Inbal","year":"1995","journal-title":"Thrombosis and Haemostasis"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:26:17Z","timestamp":1621146377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901380"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0138","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}